Maximum quantity allowed is 999
Please select the quantity
CAS RN: 761440-16-8 | Product Number: D5068
2,5-Dichloro-N-[2-(isopropylsulfonyl)phenyl]pyrimidin-4-amine
Purity: >97.0%(HPLC)(N)
Synonyms:
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
200MG |
NT$1,000
|
14 | 13 | Contact Us | |
1G |
NT$2,960
|
10 | 0 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | D5068 |
Purity / Analysis Method | >97.0%(HPLC)(N) |
Molecular Formula / Molecular Weight | C__1__3H__1__3Cl__2N__3O__2S = 346.23 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
CAS RN | 761440-16-8 |
Reaxys Registry Number | 12052746 |
PubChem Substance ID | 354333960 |
MDL Number | MFCD12827956 |
Specifications
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 97.0 area% |
Purity(with Total Nitrogen) | min. 97.0 % |
Melting point | 149.0 to 153.0 °C |
NMR | confirm to structure |
Properties (reference)
Melting Point | 151 °C |
GHS
Related Laws:
Transport Information:
H.S.code* | 2933.59-000 |
Application
A Synthetic Intermediate of Anaplastic Lymphoma Kinase (ALK) Inhibitors
This compound is used as a synthetic intermediate of anaplastic lymphoma kinase (ALK) inhibitors which have been reported their potential antitumor activities.
References
- Synthesis, Structure-Activity Relationships, and in Vivo Efficacy of the Novel Potent and Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor 5-Chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) Currently in Phase 1 and Phase 2 Clinical Trials
- Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent c-Met/ALK Multikinase Inhibitory Activities
- Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing bicyclic aminobenzazepines for anaplastic lymphoma kinase (ALK) inhibitor
- Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases
PubMed Literature
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.